A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2002
11/27/2002	CN1381249A Chinese patent medicine for treating venereal disease and puzzle dermatopathy
11/27/2002	CN1381248A Chinese patent medicine for treating venereal disease
11/27/2002	CN1381244A Plaster for treating mastitis, scrofula, nail-like deep-rooted boil and sore and its preparing process
11/27/2002	CN1094943C Urethanes and ureas that induce cytokine production
11/27/2002	CN1094942C Propiophenone derivatives and process for preparing the same
11/27/2002	CN1094930C Quinoxaline and preparation method and application thereof
11/27/2002	CN1094760C Double-layered buccal tablet of Chinese globeflower and vitamin C and its making process
11/26/2002	US6486324 Forming libraries of bactericides; immobilization; side effect reduction
11/26/2002	US6486322 Azaindole derivatives, process for their preparation, and their use as antitumor agents
11/26/2002	US6486214 Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
11/26/2002	US6486211 Indole compounds
11/26/2002	US6486200 Prodrugs for antimicrobial amidines
11/26/2002	US6486192 Indole compounds useful for treating bacterial infections
11/26/2002	US6486190 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
11/26/2002	US6486186 Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
11/26/2002	US6486183 Antivirals
11/26/2002	US6486166 Suppression of cyclin kinase 2 activity for prevention and treatment of DNA viral infections
11/26/2002	US6486150 Process for formulation of antibiotic compounds
11/26/2002	US6486149 Dissolving crystalline cefditoren pivoxil substance and the water-soluble high-molecular additive in an aqueous solution of an acid, then neutralizing the resultant solution, to co-precipitate product, and drying
11/26/2002	US6486148 Sensitize bacteria to other antibiotics; include at least two groups selected from (protected)aminoalkoxy(carbonyl), aminoalkylaminocarbonyl, aminoalkylcarbonylamino, azidoalkoxy, guanidinoalkoxy(carbonyl), and cyanoalkoxy
11/26/2002	US6486135 Nucleic acid respiratory syncytial virus vaccines
11/26/2002	US6486132 Immunomodulator, immunomodulator food and immunomodulator feed
11/26/2002	US6486125 Synthesis of soluble β-sheet forming peptides
11/26/2002	US6486122 Methods of increasing body weight in a subject by administering TGF-α
11/26/2002	US6485973 Oligonucleotides specific for the marORAB operon
11/26/2002	US6485940 Broad spectrum infectious bursal disease virus vaccine
11/26/2002	US6485929 Method for inhibiting CD95-independent apoptosis in AIDS
11/26/2002	US6485928 The t cell activation marker, granulysin for treating infections, including mycobacterium tuberculae
11/26/2002	US6485904 DNA encoding a plasminogen activating protein
11/26/2002	US6485899 Anti-bacterial methods and materials
11/26/2002	US6485755 Methods of using electron active compounds for managing cancer
11/26/2002	US6485743 Dissolved itraconazole and hydrophilic polymer with solvent, spray-dried, and prepared into solid dispersion for oral preparation
11/26/2002	US6485728 Mimicing the conformational neutralizing epitopes on papilloma virions
11/26/2002	CA2258285C Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
11/26/2002	CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002	CA2107672C Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
11/26/2002	CA2095214C Agents for the treatment of diseases caused by parasitic protozoa and neoplastic diseases
11/26/2002	CA2087164C Target specific antibody-superantigen conjugates and their preparation
11/26/2002	CA2086643C Oxepane isomers of rapamycin useful as immunosuppressive agents
11/26/2002	CA2083377C Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna
11/26/2002	CA2076465C Cell binding agent conjugates of analogues and derivatives of cc-1065
11/26/2002	CA2067275C Pharmaceutical formulation containing dirithromycin
11/22/2002	WO2002094843A1 Crystal forms of azithromycin
11/21/2002	WO2002093519A2 Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
11/21/2002	WO2002093177A2 Assays for identifying modulators of rhomboid polypeptides
11/21/2002	WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002	WO2002092826A2 Composition and method for treating cancer using herpes virus
11/21/2002	WO2002092818A2 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets
11/21/2002	WO2002092808A1 Random gene unidirectional antisense library
11/21/2002	WO2002092807A1 Unigene unidirectional antisense library
11/21/2002	WO2002092796A1 Papilloma pseud-virus and it's preparation
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092632A1 Method for preparing human immunoglobulin concentrates for therapeutic use
11/21/2002	WO2002092625A2 Moraxella(branhamella) catarrhalis antigens
11/21/2002	WO2002092616A1 Antisense permeation enhancers
11/21/2002	WO2002092605A1 CRYSTAL OF HYDRATE OF ß-LACTAM COMPOUND
11/21/2002	WO2002092600A1 Retinol derivatives potentiation of active substances by micellar preparation
11/21/2002	WO2002092597A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.0?2,11.04.9¿)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	WO2002092595A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
11/21/2002	WO2002092593A1 4-(4-pyridazinyl)pyrazole derivatives
11/21/2002	WO2002092589A2 Novel decalactones from associated fungi of marine sponges and their synthetic derivatives as medicaments
11/21/2002	WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002	WO2002092573A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
11/21/2002	WO2002092568A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002	WO2002092567A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002	WO2002092558A1 Polythiourea lipid derivatives
11/21/2002	WO2002092553A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002	WO2002092540A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms
11/21/2002	WO2002092136A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002	WO2002092131A2 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
11/21/2002	WO2002092119A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor
11/21/2002	WO2002092116A1 Targeted delivery of drugs for the treatment of viral infections
11/21/2002	WO2002092114A1 Preventives and/or remedies for fish infections
11/21/2002	WO2002092110A1 New use of natural plant polyphenol and medicament and/or health care product containing natural plant polyphenol
11/21/2002	WO2002092106A1 Taste masking pharmaceutical composition
11/21/2002	WO2002092104A1 A pharmaceutical composition comprising lysophosphatidic acid
11/21/2002	WO2002092090A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002	WO2002092089A1 Tartrate salts of 5,8,14-triazatetracyclo {10.3.1.0?2,11.04,9¿}-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	WO2002092087A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002	WO2002092079A1 Utilization of selective indirubin derivatives as vegf-r inhibitors
11/21/2002	WO2002092075A2 Therapeutic delivery of carbon monoxide
11/21/2002	WO2002092069A1 Permeation enhancers
11/21/2002	WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002	WO2002092039A1 Methods for treating or preventing diseases of the oral cavity
11/21/2002	WO2002092032A1 Use of 3-position cyclosporin derivatives for hair growth
11/21/2002	WO2002092017A2 Human antipneumococcal antibodies from non-human animals
11/21/2002	WO2002092016A2 Therapeutic use of rank antagonists
11/21/2002	WO2002092013A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	WO2002092008A2 Use of il-18 inhibitors for the treatement or prevention of sepsis
11/21/2002	WO2002092006A2 Nucleic acid-based compounds and methods of use thereof
11/21/2002	WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002	WO2002091996A2 Methods for treating cancer
11/21/2002	WO2002081728A3 Quinoline inhibitors of hyak1 and hyak3 kinases
11/21/2002	WO2002077211A8 A virus (cryptovirus) within the rubulavirus genus and uses therefor
11/21/2002	WO2002070654A3 Peptide deformylase inhibitors
11/21/2002	WO2002062318A3 Oral itraconazole formulations and methods of making the same
11/21/2002	WO2002062290A3 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
11/21/2002	WO2002046152A3 Coniosetin and derivatives thereof, method for producing the same and use thereof
11/21/2002	WO2002040536A3 Acylated antimicrobial peptides
11/21/2002	WO2002022169A3 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS

1 ... 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 ... 1798